Isolation and HPLC Quantitative Determination of 5α-Reductase Inhibitors from Tectona Grandis Leaf Extract

    April 2022 in “ Molecules
    Kamonlak Insumrong, Kornkanok Ingkaninan, Neti Waranuch, Nutchaninad Tanuphol, Wudtichai Wisuitiprot, Trinop Promgool, Nungruthai Suphrom
    Image of study
    TLDR Teak leaf extract contains compounds that could help treat hair loss.
    The study investigated Tectona grandis L.f. (teak) leaf extract as a potential treatment for hair loss. It focused on isolating and identifying 5α-reductase inhibitors, which prevent the conversion of testosterone to dihydrotestosterone, a process involved in hair loss. Three terpenoid compounds were isolated, two of which showed potent 5α-reductase inhibitory activity. An HPLC method was developed for the quantitative determination of these inhibitors, which can be used for quality control of T. grandis leaf extracts. The ethanolic extract showed a significantly higher content of these inhibitors than the hexane extract, suggesting ethanol as a preferable extraction solvent. The study recommends 95% ethanol for extracting T. grandis leaves for use in hair-loss treatment products. The study also isolated and quantified 5α-reductase inhibitors from Tectona grandis leaf extract. The ethanolic extract showed higher contents of the inhibitors compared to the hexane extract. The study isolated and identified 5α-reductase inhibitors from the leaf extract of Tectona grandis (T. grandis), a tree species. The extraction of T. grandis leaves with 95% ethanol resulted in a higher volume of extract, which contained higher concentrations of the inhibitors and exhibited greater 5α-reductase inhibitory activity than the hexane extract.
    Discuss this study in the Community →

    Research cited in this study

    14 / 14 results

    Related Community Posts Join

    6 / 92 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community NW5 at 19. How many grafts do I need?

      in Transplants  140 upvotes 1 year ago
      A 19-year-old with rapid hair loss since 16 is considering a hair transplant but refuses to take finasteride or any 5α-Reductase inhibitors. They are currently using minoxidil, tretinoin, and microneedling with a Derminator 2, and only want hair until age 27.

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 1 year ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.

    Related Research

    1 / 1 results